December 28, 2021
Shionogi said on December 27 that it has inked a commercialization agreement with Japanese health tech upstart Susmed, obtaining the exclusive marketing rights to its digital therapeutic app for insomnia in Japan. Under the pact, the Osaka-based drug maker will...read more